Pure Global AI
ANVISA registration 80134860235Active

ANTI-ADALIMUMAB ANTIBODIES (ADL)

ANVISA Registration Number: 80134860235GRIFOLS BRASIL LTDAPROGENIKA BIOPHARMA S.L.Risk Class II
Verified
Device names
Technical name
ANTI-ADALIMUMAB ANTIBODIES (ADL)
View exact technical-name matches →
PT: ANTICORPOS ANTI-ADALIMUMAB (ADL)
Commercial name
PROMONITOR ANTI-ADL
View exact commercial-name matches →
Risk class
Class II
Registration details
Registration Number
80134860235
Process Number
25351310767201695
CNPJ
02513899000171
Company information
Registration Holder
GRIFOLS BRASIL LTDA
Manufacturer
PROGENIKA BIOPHARMA S.L.
Manufacturing Country
Spain
PT: ESPANHA
Dates and status
Publication Date
Jul 03, 2017
Validity
VIGENTE
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for ANTI-ADALIMUMAB ANTIBODIES (ADL) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80134860235 and manufactured by PROGENIKA BIOPHARMA S.L.. The registration is held by GRIFOLS BRASIL LTDA with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.